Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial

In this study of hospice patients with depression and/or anxiety, oral daily ketamine liquid was given , showing excellent anxiolytic effect and a delayed antidepressant effect.

Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial